Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Rapamycin

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Rapamycin Sirolimus mTOR (mTORC1/mTORC2) PI3K-AKT-mTOR signaling Phase 1, 2, 3 Phase 2 Selleck Chemicals S1039

Cell Line (34)
Cell LineAUCGI50
SNU3980.425.011
Li70.445.15
B10.510.52
SNU8860.559.025
Huh70.552.677
JHH50.589.485
PLC.PRF50.5910.0
SNU8780.6310.0
HCC.1.20.6410.0
HCC.1.10.6510.0
JHH70.6610.0
JHH20.6610.0
JHH10.710.0
HCC.30.75.72
SNU4750.710.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it